"InDACtion" vs "3+7" Induction in AML
Phase 3 Unknown
606 enrolled
AF CRT +/- Nimorazole in HNSCC
Phase 3 Unknown
640 enrolled
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Phase 3 Unknown
1,871 enrolled
INTEGRATEIIa
Phase 3 Unknown
250 enrolled
CY25
Phase 3 Unknown
100 enrolled
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Phase 3 Unknown
813 enrolled 14 charts
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
Phase 3 Unknown
1,157 enrolled 15 charts
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
Phase 3 Unknown
637 enrolled 18 charts
DAHANCA30
Phase 3 Unknown
1,252 enrolled
H10
Phase 3 Unknown
1,952 enrolled
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Phase 3 Unknown
601 enrolled 13 charts
MAXDARA
Phase 3 Unknown
20 enrolled
R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)
Phase 3 Unknown
80 enrolled
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 3 Unknown
1,070 enrolled
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
Phase 3 Unknown
1,206 enrolled 19 charts
SURTIME
Phase 3 Unknown
99 enrolled
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
Phase 3 Unknown
686 enrolled
R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis
Phase 3 Unknown
300 enrolled
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Phase 3 Unknown
529 enrolled
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
Phase 3 Unknown
1,608 enrolled
BRiF
Phase 3 Unknown
200 enrolled
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
Phase 3 Unknown
1,258 enrolled
Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
Phase 3 Unknown
946 enrolled
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
Phase 3 Unknown
64 enrolled
TGOCphaseIII
Phase 3 Unknown
824 enrolled
AIvsAD
Phase 3 Unknown
316 enrolled
Preoperative Radiotherapy and Local Excision in Rectal Cancer
Phase 3 Unknown
102 enrolled
The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer
Phase 3 Unknown
540 enrolled
Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)
Phase 3 Unknown
205 enrolled
GIP-1
Phase 3 Unknown
400 enrolled